Boston Research & Management Inc Colgate Palmolive CO Transaction History

Boston Research & Management Inc

  • $426 Million
  • Q3 2024

A detailed history of Boston Research & Management Inc transactions in Colgate Palmolive CO stock. As of the latest transaction made, Boston Research & Management Inc holds 63,231 shares of CL stock, worth $5.91 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
63,231
Previous 62,926 0.48%
Holding current value
$5.91 Million
Previous $6.11 Million 7.5%
% of portfolio
1.54%
Previous 1.54%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$95.54 - $108.77 $29,139 - $33,174
305 Added 0.48%
63,231 $6.56 Million
Q2 2024

Aug 13, 2024
SELL
$85.85 - $98.99 $66,533 - $76,717
-775 Reduced 1.22%
62,926 $6.11 Million
Q1 2024

May 14, 2024
SELL
$79.89 - $90.05 $24,366 - $27,465
-305 Reduced 0.48%
63,701 $5.74 Million
Q4 2023

Feb 12, 2024
BUY
$68.87 - $79.71 $142,905 - $165,398
2,075 Added 3.35%
64,006 $5.1 Million
Q3 2023

Nov 13, 2023
BUY
$71.05 - $77.96 $30,196 - $33,133
425 Added 0.69%
61,931 $4.4 Million
Q2 2023

Aug 01, 2023
BUY
$74.38 - $81.98 $5,206 - $5,738
70 Added 0.11%
61,506 $4.74 Million
Q1 2023

May 10, 2023
BUY
$71.31 - $79.96 $32,089 - $35,982
450 Added 0.74%
61,436 $4.62 Million
Q4 2022

Feb 13, 2023
SELL
$68.48 - $79.94 $156,819 - $183,062
-2,290 Reduced 3.62%
60,986 $4.81 Million
Q3 2022

Nov 14, 2022
BUY
$70.25 - $82.95 $29,856 - $35,253
425 Added 0.68%
63,276 $4.45 Million
Q2 2022

Aug 11, 2022
BUY
$73.92 - $82.1 $21,806 - $24,219
295 Added 0.47%
62,851 $5.04 Million
Q1 2022

May 12, 2022
BUY
$72.2 - $85.22 $938 - $1,107
13 Added 0.02%
62,556 $4.74 Million
Q4 2021

Feb 10, 2022
BUY
$74.42 - $85.34 $34,605 - $39,683
465 Added 0.75%
62,543 $5.34 Million
Q3 2021

Nov 10, 2021
BUY
$75.58 - $84.39 $258,483 - $288,613
3,420 Added 5.83%
62,078 $4.69 Million
Q3 2021

Nov 10, 2021
SELL
$75.58 - $84.39 $39,301 - $43,882
-520 Reduced 0.88%
58,658 $4.62 Million
Q2 2021

Aug 11, 2021
BUY
$78.55 - $84.59 $40,846 - $43,986
520 Added 0.89%
59,178 $4.81 Million
Q1 2021

May 11, 2021
BUY
$74.44 - $84.52 $180,889 - $205,383
2,430 Added 4.32%
58,658 $4.62 Million
Q4 2020

Feb 09, 2021
SELL
$76.67 - $86.26 $3,450 - $3,881
-45 Reduced 0.08%
56,228 $4.81 Million
Q3 2020

Nov 09, 2020
SELL
$73.03 - $79.47 $106,331 - $115,708
-1,456 Reduced 2.52%
56,273 $4.34 Million
Q2 2020

Aug 10, 2020
BUY
$65.55 - $74.36 $12,651 - $14,351
193 Added 0.34%
57,729 $4.23 Million
Q1 2020

May 08, 2020
SELL
$59.89 - $77.35 $54,140 - $69,924
-904 Reduced 1.55%
57,536 $3.82 Million
Q4 2019

Feb 07, 2020
BUY
$65.41 - $72.07 $98,376 - $108,393
1,504 Added 2.64%
58,440 $4.02 Million
Q3 2019

Nov 12, 2019
BUY
$68.8 - $75.57 $59,512 - $65,368
865 Added 1.54%
56,936 $4.19 Million
Q2 2019

Aug 07, 2019
SELL
$67.55 - $73.99 $18,914 - $20,717
-280 Reduced 0.5%
56,071 $4.02 Million
Q1 2019

May 07, 2019
SELL
$58.97 - $68.54 $7,076 - $8,224
-120 Reduced 0.21%
56,351 $3.86 Million
Q4 2018

Feb 06, 2019
BUY
$57.88 - $67.39 $375,930 - $437,698
6,495 Added 13.0%
56,471 $3.36 Million
Q3 2018

Nov 13, 2018
SELL
$64.58 - $69.09 $143,819 - $153,863
-2,227 Reduced 4.27%
49,976 $3.35 Million
Q2 2018

Jul 30, 2018
BUY
$61.65 - $72.44 $325,203 - $382,121
5,275 Added 11.24%
52,203 $3.38 Million
Q1 2018

May 09, 2018
BUY
$68.19 - $77.5 $67,508 - $76,725
990 Added 2.16%
46,928 $3.36 Million
Q4 2017

Feb 09, 2018
SELL
$69.2 - $75.99 $116,948 - $128,423
-1,690 Reduced 3.55%
45,938 $3.47 Million
Q3 2017

Nov 09, 2017
BUY
$70.78 - $73.39 $3.37 Million - $3.5 Million
47,628
47,628 $3.47 Million

Others Institutions Holding CL

# of Institutions
2,117
Shares Held
657M
Call Options Held
4.13M
Put Options Held
4.07M
View Full List

About COLGATE PALMOLIVE CO

CL Quotes by TradingView
  • Ticker CL
  • Exchange NYSE
  • Sector Consumer Defensive
  • Industry Household & Personal Products
  • Shares Outstandng 834,120,000
  • Market Cap $78B
  • Description
  • Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, condition...
More about CL
Track This Portfolio

Track Boston Research & Management Inc Portfolio

Follow Boston Research & Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Research & Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Boston Research & Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email